Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.
25 juin 2024 08h30 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, June 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has entered into a worldwide license agreement with...
Kane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound Map
15 mai 2024 08h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, May 15, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces its intent to commercialize the patented assay...
Kane Biotech to Host Investor Webinar
16 avr. 2024 09h15 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, April 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane”) announces that it will be hosting a webinar on Thursday April 18th, 2024 at 4:15pm Eastern...
Kane Biotech Announces Improved Third Quarter 2023 Financial Results
28 nov. 2023 16h05 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its third quarter 2023 financial results. Third...
Kane Biotech to Release Third Quarter 2023 Financial Results on November 28, 2023 – Conference Call to Follow
21 nov. 2023 07h45 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech to Release First Quarter 2023 Financial Results on May 25, 2023 – Conference Call to Follow
18 mai 2023 16h05 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, May 18, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Launch of the Merkin Prize in Biomedical Technology
31 oct. 2022 13h00 HE
|
Broad Institute of MIT and Harvard
CAMBRIDGE, Mass., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Nominations are now open for the first award of the Richard N. Merkin Prize in Biomedical Technology, which recognizes novel technologies that...
Global Augmented Reality Market Predicted to Garner a Revenue of $65,323.4 Million in the 2020 to 2028 Timeframe, Growing at a Healthy CAGR of 30.9% [218-Pages] | Research Dive
28 sept. 2022 09h05 HE
|
Research Dive
New York, USA, Sept. 28, 2022 (GLOBE NEWSWIRE) -- According to Research Dive’s newly published report, the global augmented reality market is predicted to grow at a stable CAGR of 30.9%, thereby...
Akadeum Life Sciences Announces New Early Access Launch of First-of-its-Kind Microbubble-Powered, Large-Scale Cell Isolation Kit for Leukopaks
21 sept. 2022 09h00 HE
|
Akadeum Life Sciences
ANN ARBOR, Mich., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Akadeum Life Sciences, Inc., a global leader in buoyancy-based cell separation technology, announces a new early access program launch of an...
Akadeum Life Sciences Granted Transformative Patent for Buoyancy-Based Cell Separation “Microbubble” Technology
20 juin 2022 09h00 HE
|
Akadeum Life Sciences
ANN ARBOR, Mich., June 20, 2022 (GLOBE NEWSWIRE) -- Akadeum Life Sciences, Inc., a global leader in buoyancy-based technology in cell therapy manufacturing, clinical diagnostics, and cell and...